Abstract
We studied the effects of intravenous infusion of synthetic oxyntomodulin (proglucagon 33–69), a potential hormone from the ileal mucosa, on fasting and postprandial gastric acid secretion, gastric emptying, gastroduodenal motility, and pancreatic secretion of trypsin and lipase measured simultaneously in six normal volunteers using multilumen tubes for infusion of markers, manometry, and aspiration of gastric and duodenal contents. The infusion resulted in plasma concentrations of 203±21 pmollliter (mean±sem) of oxyntomodulin, regarded as high but not unphysiological concentrations of the peptide. Oxyntomodulin almost abolished basal acid secretion and inhibited postprandial acid secretion by 35±10%. Gastric emptying decreased significantly; the time for 50% to leave the stomach increased from 17.3±2.2 min to 34.7±8.0 min. The postprandial gastroduodenal motility was massively inhibited by oxyntomodulin. Postprandial trypsin and lipase output was significantly inhibited by 56±12% and 42±11%, respectively, during oxyntomodulin infusion. However, pancreatic enzyme output was linearly related to gastric emptying and oxyntomodulin did not influence this relationship, suggesting that oxyntomodulins effect was due to its effect on gastric emptying. Oxyntomodulin seems to play an important role in the small intestinal inhibitory control of gastropancreatic functions.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bataille D, Tatemoto K, Gespach C, Jörnvall H, Rosselin G, Mutt V: Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide. FEBS Lett 46:79–87, 1982
Holst JJ: Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33–69) of glicentin. Biochem J 87:372–378, 1982
Sutherland EW, DeDuve C: Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas. J Biol Chem 175:663–679, 1948
Bataille D, Coudray AM, Carlqvist M, Rosselin G, Mutt V: Isolation of glucagon 37 (bioactive enteroglucagon/oxyntomodulin from porcine jejuno-ileum. Isolation of the peptide. FEBS Lett 46:73–78, 1982
Baldissera FGA, Holst JJ: Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 26:223–228, 1984
Munck A, Kervran A, Marie JC, Bataille D, Rosselin G: Glucagon 37 (oxyntomodulin) and glucagon 29 (pancreatic glucagon) in human bowel: Analysis by HPLC and radioreceptor assay. Peptides 5:553–561, 1984
Thim L, Moody AJ, Valverde I: Structure determination of glicentin (33-69) isolated from a single human intestine. Dig Dis Sci 29(suppl):A-88, 1984
Holst JJ: Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon producing tumors. Diabetologia 24:359–365, 1983
Holst JJ, Holst Pedersen J, Baldissera FGA, Stadil F: Circulating glucagon after total pancreatectomy in man. Diabetologia 25:396–399, 1983
Kervran A, Blache P, Bataille D: Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. Endocrinology 121:807–813, 1987
Baldissera FGA, Holst JJ, Knuhtsen S, Hilsted L, Nielsen OV: Oxyntomodulin (glicentin 33-69): pharmacokinetics; binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs. Regul Pept 21:151–166, 1988
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF: Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261:11880–11889, 1986
Holst JJ, Olsen J, Lund T: Are the enteroglucagons encoded by the glucagon gene? Diabetologia 30:532A, 1987
Holst JJ: Enteroglucagon.In Advances in Metabolic Disorders. V. Mutt (ed). New York, Academic Press, 1988, pp 392–419
Holst JJ: Interactions of hepatocyte membrane receptors with pancreatic and gut glucagon.In Glucagon: Its Role in Physiology and Clinical Medicine. PP Foa, JS Baja, NL Foa (eds). New York, Springer Verlag, 1977, pp 2087–2303
Jarrousse C, Bataille D, Jeanrenaud B: A pure enteroglucagon oxyntomodulin (glucagon-37), stimulates insulin release in perfused rat pancreas. Endocrinology 115:102–105, 1984
Bataille D, Gespach C, Coudray AM, Rosselin G: Enteroglucagon: A specific effect on gastric glands isolated from the rat fundus. Evidence for an oxyntomodulin action. Biosci Rep 1:151–155, 1981
Dubrasquet M, Bataille D, Gespach C: Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin stimulated acid secretion in rats. Biosci Rep 2:391–395, 1982
Bataille D, Gespach C, Tatemoto K, Marie JC, Coudray AM, Rosselin G, Mutt V: Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities. Peptides 2:41–44, 1981
Jarrousse C, Niel H, Audousset-Puech M-P, Martinez J, Bataille D: Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion. Peptides 7:253–256, 1986
Schjoldager B, Baldissera FGA, Mortensen PE, Christiansen J, Holst JJ: Oxyntomodulin, a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid secretion in man. Eur J Clin Invest 18:499–503, 1988
Biedzinski TM, Bataille D, Devaux MA, Sarles H: The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat. Peptides 8:967–972, 1987
Lawaetz O, Ohlsen HP, Andreasen R: Evaluation of gastric emptying by a single isotope technique. Scand J Gastroenterol 16:737–748, 1981
Holst JJ, Christiansen J, Kuhl C: The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in man. Scand J Gastroenterol 11:297–304, 1976
Holst JJ, Schwartz TW, Lovgren NA, Pedersen O, Beck-Nielsen H: Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obes 7:529–538, 1983
Polonsky KS, Jaspan JB, Rubenstein AH: The metabolic clearance rate of glucagon.In Glucagon. Handbook of Experimental Pharmacology. PJ Lefebvre (ed). New York, Springer Verlag, 1983, pp 353–359
Go VLW, Hofmann AF, Summerskill WHJ: Simultaneous measurements of total pancreatic, biliary and gastric outputs in man using a perfusion technique. Gastroenterology 58:321–328, 1970
Dimagno EP: Alterations and consequences of interdigestive and poststimulatory human exocrine pancreatic secretion in health and disease. Scand J Gastroenterol 12(suppl 87):69, 1983
Worning H, Mullertz S: pH and pancreatic enzymes in the human duodenum during digestion of a standard meal. Scand J Gastroenterol 1:268–283, 1966
Holst JJ, Creutzfeldt M, Holm G, Jensen E, Poulsen D, Sparsø Birgitte, Sparsø B, Schmidt A: Persistent glucagonemia after pancreatectomy in pigs. Diabete Metab 4:75–79, 1978
Hilsted L, Holst JJ: On the accuracy of radioimmunological determination of somatostatin in plasma. Regul Pept 4:13–31, 1982
Widdonson GM, Penton JR: Determination of serum and plasma glucose on “autoanalyzer II” by use of hexokinase reaction. Clin Chem 18:299–300, 1972
Malagelada J-R, Longstreth GF, Summerskill WHJ, Go VLW: Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 70:203–210, 1976
Christiansen J, Holst JJ, Kalaja E: Inhibition of gastric acid in man by exogenous and exogenous pancreatic glucagon. Gastroenterology 70:688–692, 1976
Thomas PA, Akvari OE, Kelly KA: Hormonal control of gastrointestinal motility. World J Surg 3:543–552, 1979
Miller RE, Chernish SM: The response of gastrointestinal tract motility to glucagon.In Glucagon in Gastroenterology and Hepatology. J Picazo (ed). Boston, MTP Press, 1982, pp 37–54
Dyck WP, Texter EC, Lasater JM, Hightower NC: Interfluence of glucagon on pancreatic exocrine secretion in man. Gastroenterology 58:532–539, 1970
Samols E:In Glucagon. Handbook of Experimental Pharmacology. PJ Lefebvre (ed). New York, Springer Verlag, 1983, pp 448–518
Rees WDW, Go VLW, Malagelada J-R: Simultaneous measurement of antroduodenal motility, gastric emptying, and duodenogastric reflux in man. Gut 20:963–970, 1979
Schjoldager B, Lawaetz O, Christiansen J: Effect of pancreatic glucagon and its 1–21 fragment on gastric emptying in man. Scand J Gastroenterol 23:726–730, 1988
Miller LJ, Malagelada J-R, Taylor WF, Go VLW: Intestinal control of postprandial gastric function: The role of components of jejunoileal chyme in regulating gastric secretion and gastric emptying. Gastroenterology 80:763–769, 1981
Walsh JH: Gastrointestinal Hormones.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven Press, 1987, pp 246–257
Solomon TE: Control of exocrine pancreatic secretion.In Physiology of the Gastrointestinal Tract. LR Johnson (ed). New York, Raven Press, 1987, pp 1173–1207
Author information
Authors and Affiliations
Additional information
This study was supported by grants from the Danish Medical Research Council and Lægeforeningens Forskningsfond.
Rights and permissions
About this article
Cite this article
Schjoldager, B., Mortensen, P.E., Myhre, J. et al. Oxyntomodulin from distal gut. Digest Dis Sci 34, 1411–1419 (1989). https://doi.org/10.1007/BF01538078
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01538078